Notes
Slide Show
Outline
1
Compound Solubility and HTS Screening
  • Christopher A. Lipinski
  • Adjunct Senior Research Fellow
  • Pfizer Global R&D, Groton Labs
  • Christopher_A_Lipinski@Groton.Pfizer.Com
2
The symptoms to be concerned about
  • Erratic HTS screening results that seem to bear little or no relationship to the biology and maybe even to the chemistry
    • erratic rates of primary hits in HTS screens
    • erratic re-confirm rates on primary HTS actives
    • differences among screening sites
    • differences among compound collections
3
Minimum Acceptable Solubility in ug/mL Bars shows the minimum solubility for low, medium and high permeability (Ka) at a clinical dose. The critical range for aqueous and DMSO solubility is around 10 uM
4
14.2 Percent of 1597 phase II compounds have low aqueous solubility (<20 ug/mL)
5
31.2 Percent of 2246 commercial compounds have low aqueous solubility (<= 20 ug/mL)
6
39.8 Percent of 33093 medicinal chemistry compounds have low solubility (<= 20 ug/mL)
7
Evidence for 35-40% poor aqueous solubility
  • 70,000 compounds screened at Pfizer, Groton
  • Capsugel Symposium June 2003 Tokyo
    • solubility formulation, customer feedback
  • Collaborator feedback to Matrical
    • “Sonicman” HTS plate based sonicator
8
Dimension of the solubility problem
  • 40% of compounds have poor aqueous solubility
  • Half the problem due to size / lipophilicity
  • Half the problem due to crystal packing
  • DMSO no better than water for compounds insoluble due to crystal packing
  • Suggests an upper limit of 20% compounds  insoluble in dry DMSO at 10uM
  • Will this limit ever be achieved?
  • Depends on whether a nucleation event occurs
  • Depends on number of freeze thaw cycles
9
Compounds differ in aqueous and DMSO solubility based on crystalline form
  • Ostwalds “rule of stages”
  • Sequence of compound batch isolation proceeds towards thermodynamically most stable form
    • 1 - amorphous - highest energy solid form
    • 2 - highest energy crystalline polymorph
    • 3 - lowest energy crystalline polymorph
  • Amorphous is the highest energy form
    • most soluble in water and DMSO


10
Early discovery compound purity
  • Pressure on chemistry to increase output
    • crystallization has disappeared
  • Combinatorial compounds are now being purified by automated procedures
    • 90% pure by evaporative light scattering
    • 80% pure by UV detection
  • Compounds “appear” more soluble
    • amorphous state
    • impurities enhance solubility
11
Fraction of Pfizer Groton compounds having melting point field information
12
Consequences of amorphous compounds
  • Amorphous DMSO solubility is always higher than when compound is crystalline
  • Amorphous compounds from combichem or medchem initially easily dissolve in DMSO
    • allows preparation of DMSO stocks
  • Sets stage for later precipitation problems
13
Thermodynamic aqueous solubility
14
Metastable supersaturated zone
15
Unstable supersaturated zone
16
Water and DMSO solubility
  • Large, lipophilic compound
    • aqueous insoluble
    • DMSO greatly helps aqueous solubility
  • Very crystalline compound
    • may show no computational problem
    • no “rule of 5” violation
    • aqueous insoluble
    • high melting point
    • strong intermolecular crystal lattice
    • DMSO does not help aqueous solubility
17
DMSO really helps aqueous solvation problems when the problem is size / lipophilicity
  • Compound has to make a “hole” in DMSO to dissolve
  • easier to do this in DMSO than in water
    • no H-bond donor / acceptor networks to disrupt
  • DMSO has a high dielectric constant
  • solvates compound dipoles
    • almost all drugs have dipoles

18
Sample storage in DMSO
19
Sample in DMSO lifetime
  • Compound disappears from DMSO solution
  • What is the explanation?
  • Chemical integrity in DMSO
    • keep cold and frozen
    • avoid oxygen
    • keep dry
  • Compound solubility in DMSO
    • cold and / or frozen is the worst choice possible
    • avoid freeze thaw cycles
20
DMSO – water phase diagram
21
Timing factor in compound DMSO solubility
  • Once a compound crystallizes from  DMSO it will not easily re-dissolve
    • crystallized compound is in a lower energy, higher melting point, less DMSO soluble form
  • Narrow working window (time window) for keeping most compounds dissolved in DMSO
    • 1 to 2 days at room temperature
    • explains why compounds are active when freshly made but not when stored
  • Freeze thaw cycles increase the probability of crystallization
22
Summary
  • Crystalline state is important to aqueous solubility
  • Crystalline state is important to DMSO solubility
    • be alert for compound precipitation from DMSO
    • do not store liquid DMSO stocks in the refrigerator
    • minimize time once DMSO stocks are diluted
    • expect erratic HTS screening results dependent on minor compound handling differences
    • minimize freeze thaw cycles
  • Poor DMSO solubility is here to stay


23
Recent Developments in DMSO solubility
  • New Software
  • DMSO solubility prediction software
  • Pharma Algorithms
    • http://ap-algorithms.com/dmso.html
  • Chemical Diversity Labs
    • http://www.currentdrugdiscovery.com/pdf/2003/500632.pdf


  • New Hardware
  • Matrical
    • “SonicMan” plate based sonicator
      • http://www.matrical.com/Literature/SonicManFlier.pdf
24
Acknowledgements
  • The generous support of Pfizer Global R&D, Groton Labs in my post retirement activities is gratefully acknowledged